Declotting grafts with thrombolysis

Jeffrey L. Lautin, Jacob Cynamon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Percutaneous declotting of dialysis grafts has been evolving since its introduction in the early 1980s. At first, a low-dose thrombolytic infusion through a single catheter was used. Crossing catheters with a higher dose infusion was then introduced. The next method used was a pharmacomechanical thrombolysis, which uses crossing catheters and pulse-spray technique. Mechanical displacement of the platelet plug at the arterial anastomosis is necessary. Residual clot in the midgraft is mobilized with Fogarty balloons and/or angioplasty balloons. The underlying cause of graft failure, which is typically a stenosis at the venous anastomosis, must be addressed. The viability of a graft after successful lysis is probably most dependent on successful treatment of the lesion that caused the graft to thrombose. If an angioplasty of this lesion is not successful, one can consider directional atherectomy or stents. Alternatively, a surgical repair with a patch angioplasty or with an interposition graft can be performed. Recently, alternative declotting devices have been introduced. The Amplatz device and the Possis device are 2 such devices. Additionally, aspiration thrombectomy is being used with or without addition of lytic agents to attempt to declot grafts. These newer devices and techniques must be shown to be similar in terms of efficacy and cost when compared to pharmaco-mechanical thrombolysis before being considered for widespread use. Ultimately, it is the management of the platelet plug at the arterial anastomosis and the venous stenosis that will determine how long the graft will function after the procedure. The lyse and wait (L&W) technique was described in 1997 as a quick and simple method to declot arteriovenous (AV) grafts. A 250,000 U urokinase (5 mL), 5,000 U heparin (1 mL) mixture (total 6 mL) is injected into the graft via a 22-gauge angiocatheter. This mixture is allowed to sit in the graft for 30 to 60 minutes. The same technique can be used with any lytic agent. A multicenter randomized prospective study comparing pulse-spray pharmacomechanical thrombolysis versus L&W was recently completed. Eighty-eight patients were randomized. L&W on the average was 20 minutes quicker than pulse-spray with similar technical success and patencies. With similar results and faster procedure times, we believe L&W to be a good alternative for dialysis graft declotting.

Original languageEnglish (US)
Pages (from-to)217-220
Number of pages4
JournalTechniques in Vascular and Interventional Radiology
Volume2
Issue number4
DOIs
StatePublished - 1999

Fingerprint

Transplants
Equipment and Supplies
Catheters
Angioplasty
Dialysis
Pathologic Constriction
Mechanical Thrombolysis
Blood Platelets
Atherectomy
Thrombectomy
Balloon Angioplasty
Urokinase-Type Plasminogen Activator
Stents
Heparin
Thrombosis
Prospective Studies
Costs and Cost Analysis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Declotting grafts with thrombolysis. / Lautin, Jeffrey L.; Cynamon, Jacob.

In: Techniques in Vascular and Interventional Radiology, Vol. 2, No. 4, 1999, p. 217-220.

Research output: Contribution to journalArticle

@article{10cff7b9c37642e386afae7b03adf0e7,
title = "Declotting grafts with thrombolysis",
abstract = "Percutaneous declotting of dialysis grafts has been evolving since its introduction in the early 1980s. At first, a low-dose thrombolytic infusion through a single catheter was used. Crossing catheters with a higher dose infusion was then introduced. The next method used was a pharmacomechanical thrombolysis, which uses crossing catheters and pulse-spray technique. Mechanical displacement of the platelet plug at the arterial anastomosis is necessary. Residual clot in the midgraft is mobilized with Fogarty balloons and/or angioplasty balloons. The underlying cause of graft failure, which is typically a stenosis at the venous anastomosis, must be addressed. The viability of a graft after successful lysis is probably most dependent on successful treatment of the lesion that caused the graft to thrombose. If an angioplasty of this lesion is not successful, one can consider directional atherectomy or stents. Alternatively, a surgical repair with a patch angioplasty or with an interposition graft can be performed. Recently, alternative declotting devices have been introduced. The Amplatz device and the Possis device are 2 such devices. Additionally, aspiration thrombectomy is being used with or without addition of lytic agents to attempt to declot grafts. These newer devices and techniques must be shown to be similar in terms of efficacy and cost when compared to pharmaco-mechanical thrombolysis before being considered for widespread use. Ultimately, it is the management of the platelet plug at the arterial anastomosis and the venous stenosis that will determine how long the graft will function after the procedure. The lyse and wait (L&W) technique was described in 1997 as a quick and simple method to declot arteriovenous (AV) grafts. A 250,000 U urokinase (5 mL), 5,000 U heparin (1 mL) mixture (total 6 mL) is injected into the graft via a 22-gauge angiocatheter. This mixture is allowed to sit in the graft for 30 to 60 minutes. The same technique can be used with any lytic agent. A multicenter randomized prospective study comparing pulse-spray pharmacomechanical thrombolysis versus L&W was recently completed. Eighty-eight patients were randomized. L&W on the average was 20 minutes quicker than pulse-spray with similar technical success and patencies. With similar results and faster procedure times, we believe L&W to be a good alternative for dialysis graft declotting.",
author = "Lautin, {Jeffrey L.} and Jacob Cynamon",
year = "1999",
doi = "10.1016/S1089-2516(99)80121-8",
language = "English (US)",
volume = "2",
pages = "217--220",
journal = "Techniques in Vascular and Interventional Radiology",
issn = "1089-2516",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Declotting grafts with thrombolysis

AU - Lautin, Jeffrey L.

AU - Cynamon, Jacob

PY - 1999

Y1 - 1999

N2 - Percutaneous declotting of dialysis grafts has been evolving since its introduction in the early 1980s. At first, a low-dose thrombolytic infusion through a single catheter was used. Crossing catheters with a higher dose infusion was then introduced. The next method used was a pharmacomechanical thrombolysis, which uses crossing catheters and pulse-spray technique. Mechanical displacement of the platelet plug at the arterial anastomosis is necessary. Residual clot in the midgraft is mobilized with Fogarty balloons and/or angioplasty balloons. The underlying cause of graft failure, which is typically a stenosis at the venous anastomosis, must be addressed. The viability of a graft after successful lysis is probably most dependent on successful treatment of the lesion that caused the graft to thrombose. If an angioplasty of this lesion is not successful, one can consider directional atherectomy or stents. Alternatively, a surgical repair with a patch angioplasty or with an interposition graft can be performed. Recently, alternative declotting devices have been introduced. The Amplatz device and the Possis device are 2 such devices. Additionally, aspiration thrombectomy is being used with or without addition of lytic agents to attempt to declot grafts. These newer devices and techniques must be shown to be similar in terms of efficacy and cost when compared to pharmaco-mechanical thrombolysis before being considered for widespread use. Ultimately, it is the management of the platelet plug at the arterial anastomosis and the venous stenosis that will determine how long the graft will function after the procedure. The lyse and wait (L&W) technique was described in 1997 as a quick and simple method to declot arteriovenous (AV) grafts. A 250,000 U urokinase (5 mL), 5,000 U heparin (1 mL) mixture (total 6 mL) is injected into the graft via a 22-gauge angiocatheter. This mixture is allowed to sit in the graft for 30 to 60 minutes. The same technique can be used with any lytic agent. A multicenter randomized prospective study comparing pulse-spray pharmacomechanical thrombolysis versus L&W was recently completed. Eighty-eight patients were randomized. L&W on the average was 20 minutes quicker than pulse-spray with similar technical success and patencies. With similar results and faster procedure times, we believe L&W to be a good alternative for dialysis graft declotting.

AB - Percutaneous declotting of dialysis grafts has been evolving since its introduction in the early 1980s. At first, a low-dose thrombolytic infusion through a single catheter was used. Crossing catheters with a higher dose infusion was then introduced. The next method used was a pharmacomechanical thrombolysis, which uses crossing catheters and pulse-spray technique. Mechanical displacement of the platelet plug at the arterial anastomosis is necessary. Residual clot in the midgraft is mobilized with Fogarty balloons and/or angioplasty balloons. The underlying cause of graft failure, which is typically a stenosis at the venous anastomosis, must be addressed. The viability of a graft after successful lysis is probably most dependent on successful treatment of the lesion that caused the graft to thrombose. If an angioplasty of this lesion is not successful, one can consider directional atherectomy or stents. Alternatively, a surgical repair with a patch angioplasty or with an interposition graft can be performed. Recently, alternative declotting devices have been introduced. The Amplatz device and the Possis device are 2 such devices. Additionally, aspiration thrombectomy is being used with or without addition of lytic agents to attempt to declot grafts. These newer devices and techniques must be shown to be similar in terms of efficacy and cost when compared to pharmaco-mechanical thrombolysis before being considered for widespread use. Ultimately, it is the management of the platelet plug at the arterial anastomosis and the venous stenosis that will determine how long the graft will function after the procedure. The lyse and wait (L&W) technique was described in 1997 as a quick and simple method to declot arteriovenous (AV) grafts. A 250,000 U urokinase (5 mL), 5,000 U heparin (1 mL) mixture (total 6 mL) is injected into the graft via a 22-gauge angiocatheter. This mixture is allowed to sit in the graft for 30 to 60 minutes. The same technique can be used with any lytic agent. A multicenter randomized prospective study comparing pulse-spray pharmacomechanical thrombolysis versus L&W was recently completed. Eighty-eight patients were randomized. L&W on the average was 20 minutes quicker than pulse-spray with similar technical success and patencies. With similar results and faster procedure times, we believe L&W to be a good alternative for dialysis graft declotting.

UR - http://www.scopus.com/inward/record.url?scp=0000502778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0000502778&partnerID=8YFLogxK

U2 - 10.1016/S1089-2516(99)80121-8

DO - 10.1016/S1089-2516(99)80121-8

M3 - Article

VL - 2

SP - 217

EP - 220

JO - Techniques in Vascular and Interventional Radiology

JF - Techniques in Vascular and Interventional Radiology

SN - 1089-2516

IS - 4

ER -